---
title: South Korea’s SK Group Makes Biotech Push With $1.3 Billion IPO Of Covid Vaccine
  Unit
date: "2021-03-17 06:40:01"
author: Forbes - Innovation
authorlink: https://www.forbes.com/sites/ralphjennings/2021/03/17/south-koreas-sk-group-makes-biotech-push-with-13-billion-ipo-of-covid-vaccine-unit/
tags:
- Forbes-Innovation
---
The IPO of SK Bioscience is the latest push by Korean billionaire Chey Tae-won’s SK Group—which is known for its memory chip and electric vehicle battery businesses—to expand into another hot market: Biotech.